MaxCyte Inc (LSE:MXCT)
ÂŁ 2.85 -0.06 (-2.06%) Market Cap: 299.50 Mil Enterprise Value: 192.38 Mil PE Ratio: 0 PB Ratio: 1.72 GF Score: 78/100

MaxCyte Inc at ShareSoc Webinar Transcript

Feb 08, 2022 / NTS GMT
Release Date Price: ÂŁ4.23 (+0.60%)
Karin Schulte
ShareSoc - Member of the Board of Directors

I'd now like to hand over to Doug Doerfler, who is the President and CEO of MaxCyte PLC and also the Founder. Welcome to you, Doug. I believe it's morning time where you are. We look forward to hearing all about MaxCyte and I shall come back a little bit later for the Q&A.

Doug Doerfler
MaxCyte, Inc. - President & CEO

Thank you, Karin, and thank you, everyone, for attending this update on MaxCyte and I seriously thank ShareSoc for hosting this event. Great to see so many existing shareholders of MaxCyte. Thank you for your support and I look forward to providing an update. And those of you who are new to the story, I look forward to giving you a background on the company.

MaxCyte is currently listed on London Stock Exchange, on the AIM exchange. We're also listed as of July of 2021 on the US NASDAQ. So, please refer to written documents for any forward-looking statements.

So, next slide, please. So, a little background on MaxCyte. So, we are focused in the area of cell

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot